Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy

Author： Li F.   Szabó C.   Pacher P.   Southan G.   Abatan O.   Charniauskaya T.   Stevens M.   Obrosova I.  

Publisher： Springer Publishing Company

ISSN： 0012-186X

Source： Diabetologia, Vol.47, Iss.4, 2004-04, pp. : 710-717

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Role for Poly(ADP-ribose) Polymerase Activation in Diabetic Nephropathy, Neuropathy and Retinopathy

By  

Current Vascular Pharmacology, Vol. 3, Iss. 3, 2005-07 ,pp. : 267-283

Bentham Science Publishers

Access to resources Recommend Favorite

Poly(ADP-ribose) polymerase and aging - A critical analysis

By Burkle A.  

Experimental Gerontology, Vol. 33, Iss. 6, 1998-09 ,pp. : 519-523

Elsevier

Access to resources Recommend Favorite

Role of Nitrosative Stress and Poly(ADP-ribose) Polymerase Activation in Diabetic Vascular Dysfunction

By  

Current Vascular Pharmacology, Vol. 3, Iss. 3, 2005-01 ,pp. : 247-252

Bentham Science Publishers

Access to resources Recommend Favorite

Poly(ADP-ribose) polymerase-1, DNA repair and mammalian longevity

By Burkle A.   Beneke S.   Brabeck C.   Leake A.   Meyer R.   Muiras M.-L.   Pfeiffer R.  

Experimental Gerontology, Vol. 37, Iss. 10, 2002-10 ,pp. : 1203-1205

Elsevier

Access to resources Recommend Favorite

Pharmacological Inhibition of Poly(ADP-ribose) Polymerase in Cardiovascular Disorders: Future Directions

By  

Current Vascular Pharmacology, Vol. 3, Iss. 3, 2005-07 ,pp. : 301-303

Bentham Science Publishers

Access to resources Recommend Favorite